Paper Details

  1. Home
  2. Paper Details

Rolapitant: A Review in Chemotherapy-Induced Nausea and Vomiting.

Author: DeeksEmma D, HeoYoung-A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review discusses the use of oral rolapitant, a neurokinin-1 (NK1) receptor antagonist, for preventing delayed chemotherapy-induced nausea and vomiting (CINV). The review highlights its effectiveness and tolerability in adults receiving highly or moderately emetogenic chemotherapy.
Paper Details　
Original Abstract of the Article :
Oral rolapitant (Varubi&#8482;; Varuby<sup>&#174;</sup>), a long-acting neurokinin-1 (NK<sub>1</sub>) receptor antagonist (RA), is indicated in the USA and EU as part of an antiemetic regimen to prevent delayed chemotherapy-induced nausea and vomiting (CINV) in adults receiving highly or moderately ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s40265-017-0816-z

データ提供：米国国立医学図書館（NLM）

Rolapitant: A New Weapon in the Fight Against Chemotherapy-Induced Nausea and Vomiting

Chemotherapy, a powerful tool in the fight against cancer, often comes with debilitating side effects. Imagine a desert traveler, battling the scorching sun and dehydration, seeking relief from the harsh conditions. Chemotherapy-induced nausea and vomiting (CINV) is a common and distressing side effect that can severely impact a patient's quality of life. This research explores the effectiveness of rolapitant, a new drug, in preventing this debilitating condition.

A Promising Solution for a Common Problem

The study found that rolapitant was effective in preventing delayed CINV, offering relief from the persistent nausea and vomiting that can plague cancer patients. It's like finding a cool spring in the desert, offering a respite from the unrelenting heat and providing much-needed hydration.

A New Frontier in Cancer Treatment

This research provides valuable insights into the management of CINV. Rolapitant's effectiveness in preventing this debilitating side effect offers a new frontier in cancer treatment, providing much-needed relief for patients and improving their quality of life. It's like discovering a new oasis in the desert, offering respite and replenishment to weary travelers.

Dr. Camel's Conclusion

The journey through cancer treatment can be arduous and challenging. This research offers hope by providing a new tool for managing CINV, offering relief from a common and debilitating side effect. We must continue to search for new oases in the desert of cancer treatment, always striving to improve the lives of those who are battling this disease.

Date :
  1. Date Completed 2019-01-09
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

28929404

DOI: Digital Object Identifier

10.1007/s40265-017-0816-z

Related Literature

Article Analysis
・Effects of rolapitant
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.